Profile
Jean-Francois H.
Geschwind is associated with two companies, Sentient Technology, Inc. and Cage Pharma, Inc. He is the founder of both companies.
Sentient Technology, Inc. was founded in 2008, and no title is mentioned for him.
Cage Pharma, Inc. is also founded in 2008, and he holds the title of Chief Executive Officer & Director, which he still holds.
Jean-Francois H. Geschwind active positions
Companies | Position | Start |
---|---|---|
Cage Pharma, Inc.
Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD. | Founder | 24/10/2008 |
Former positions of Jean-Francois H. Geschwind
Companies | Position | End |
---|---|---|
Sentient Technology, Inc.
Sentient Technology, Inc. Medical SpecialtiesHealth Technology Sentient Bioscience, Inc. develops technology for embolization therapy and site-specific drug delivery to treat cancer and other diseases. The company was founded by Jean Francois H. Geschwind, Edith Mathiowitz and Timothy Murphy on August 14, 2008 and is headquartered in Providence, RI. | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Sentient Technology, Inc.
Sentient Technology, Inc. Medical SpecialtiesHealth Technology Sentient Bioscience, Inc. develops technology for embolization therapy and site-specific drug delivery to treat cancer and other diseases. The company was founded by Jean Francois H. Geschwind, Edith Mathiowitz and Timothy Murphy on August 14, 2008 and is headquartered in Providence, RI. | Health Technology |
Cage Pharma, Inc.
Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD. | Health Technology |
- Stock Market
- Insiders
- Jean-Francois H. Geschwind